Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Alert
Watchlist
Jenburkt Pharmaceuticals
₹1,073.55
+23.75 (2.26%) 1D
Create Stock SIPAutomate your investments in this
Performance
Open
1,049.80Prev. Close
1,049.80Volume
375Total traded value
0.04 CrUpper Circuit
1,259.75Lower Circuit
839.85Fundamentals
| Market Cap | ₹463Cr |
| ROE | 18.66% |
| P/E Ratio(TTM) | 14.28 |
| EPS(TTM) | 73.50 |
| P/B Ratio | 2.70 |
| Dividend Yield | 1.71% |
| Industry P/E | 39.79 |
| Book Value | 389.23 |
| Debt to Equity | 0.02 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Jenburkt Pharma
Jenburkt is a pharmaceutical company that has established itself as a leader in pain management and primary care in India, with over four decades of experience. The company is guided by a core philosophy of prioritizing patients, aiming to transform lives one patient, one family, and one community at a time. Today, its leading brand Nervijen ranks as number 6 in the Vitamin, Mineral and Nutrients category within the highly competitive Indian market.;
| Parent Organisation | Jenburkt Pharmaceuticals Limited |
| Managing Director | Shri. Ashish Bhuta |
| BSE Symbol | 524731 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.29 | ||
| Gland Pharma | NA (0.00%) | 41.84 | ||
| Ajanta Pharma | NA (0.00%) | 32.36 | ||
| Eris Lifesciences | NA (0.00%) | 53.04 |